NeuroSense Therapeutics Ltd. (NRSNW) has a market capitalization of $4.88M and trades at $0.20. The 52-week range is 0.2-0.3.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.4, Earnings Per Share (EPS) of $-0.55.
The stock has a beta of 1.68, operates in the Healthcare sector.
